Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

ArQule Inc. (ARQL)

-NasdaqGM
1.66 Down 0.05(2.92%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:1.71
Open:1.69
Bid:1.20 x 5000
Ask:1.85 x 400
1y Target Est:3.56
Beta:1.23
Earnings Date:May 5 - May 9 (Est.)
Day's Range:1.62 - 1.75
52wk Range:1.62 - 3.10
Volume:530,559
Avg Vol (3m):330,015
Market Cap:104.35M
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Reports

Comparison

Symbol% ChgMkt Cap
ARQLDown 2.92%104.35M
ARRYDown 1.30%475.48M
ASTX 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.49
Quarterly EPS Est (Mar-14) :-0.11
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ArQule, Inc., a clinical-stage biotechnology company, researches and develops cancer therapeutics. Its lead product candidate tivantinib is an inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase 3 clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback